AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival ("DFS") expected in H1 2025Poster presentation at the Society for Im ...

In August 2024, Elicio received a $1.5M grant from the Gastro-Intestinal Research Foundation to support continued development of vaccines targeting p53 and BRAF mutations. In July 2024, a $11.5M ...

EGFR Mutation Testing on Cytological and Histological Samples in ... Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation. Pathol Int.

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Aprea Therapeutics (APRE – Research Report), ...

Ongoing phase III trials in low-grade glioma seek to determine the role of temozolomide in management of these tumors. The first trial, European Organization for Research and Treatment of Cancer ...

Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, ...

Mutation or dysregulation of tumour-suppressor proteins can lead to unregulated cell growth and tumour development. A review summarizes the recent advances in ferroptosis and tumor suppression ...

Nov. 11, 2024 — A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer ... DNA Packaging Directly Affects How Fast ...

Their findings pave the ... Cancer Risk Linked to P53 in Ulcerative Colitis Oct. 25, 2024 — Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a ...